Lapatinib Ditosylate

14000 INR

Get a Price/Quote

Product Details:

Drug Type Specific Drug
Physical Form Tablets
Function Anti-Cancer
Suitable For Adults
Storage Instructions Dry Place
Supply Ability : 1 Crore Per Week
Click to view more
Share Your Product:

Ask A Question Send Inquiry

Price And Quantity

Price 14000 INR
Minimum Order Quantity 1 Crore Piece

Product Specifications

Drug Type Specific Drug
Storage Instructions Dry Place
Suitable For Adults
Physical Form Tablets
Function Anti-Cancer

Trade Information

Payment Terms Cash in Advance (CID), Cash Advance (CA)
Supply Ability 1 Piece Crore Per Week
Delivery Time 1 Week
Main Export Market(s) Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia

Product Description

Lapatinib Ditosylate Tablet

Lapatinib is an anti-cancer drug used as a treatment for solid tumours such as breast and lung cancer. It was approved by the FDA on March 13, 2007, for use in patients with advanced metastatic breast cancer in conjunction with the chemotherapy drug Capecitabine. Lapatinib is human epidermal growth factor receptor type 2 (HER2/ERBB2) and epidermal growth factor receptor (HER1/EGFR/ERBB1) tyrosine kinases inhibitor. It binds to the intracellular phosphorylation domain to prevent receptor autophosphorylation upon ligand binding.

Features: